Viewing Study NCT01832506


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2026-01-14 @ 1:15 AM
Study NCT ID: NCT01832506
Status: COMPLETED
Last Update Posted: 2020-08-06
First Post: 2013-04-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-04-30
Start Date Type: ACTUAL
Primary Completion Date: 2014-03-31
Primary Completion Date Type: ACTUAL
Completion Date: 2014-10-31
Completion Date Type: ACTUAL
First Submit Date: 2013-04-05
First Submit QC Date: None
Study First Post Date: 2013-04-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-10-14
Results First Submit QC Date: None
Results First Post Date: 2016-12-07
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-07-23
Last Update Post Date: 2020-08-06
Last Update Post Date Type: ACTUAL